Trial intelligence / Profile preview

Bioequivalence of finasteride 1 mg tablet versus Propecia 1 mg tablet in healthy Thai male volunteers under fasting

TCTR20220923001Phase 1Unknown

Sponsor
Bio-innova
Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of finasteride in androgenetic alopecia (AGA) (2 arms), sponsored by Bio-innova. Status: unknown.

02

Drugs

finasteride
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on TCTR20220923001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20220923001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call